APP, in conjunction with the FDA, began importing Fresenius Propoven 1% in late 2009 but stopped in Feb. 2010 when the initial supply ran out, according to the letter.
Effective immediate, APP, which is the only company authorized to import Fresenius Propoven 1%, will begin importing the following products:
- DIPRIVAN (20-mL, 50-MI and 100-mL vials)
- APP Propofol 1% (20-mL, 50-MI and 100-mL vials)
- Fresenius Propoven 1% (20-mL, 50-MI and 100-mL vials)
The letter also notes some important difference between U.S.-manufactured propofol and international Fresenius Propoven 1%, including contraindication in patients with peanut and soy allergies. For complete information on the difference, please refer to the APP’s letter.
Read APP’s letter on Fresenius Propoven 1% (pdf).
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
